Search

Zai Lab Ltd ADR

Fechado

SetorSaúde

23 -2.04

Visão Geral

Variação de preço das ações

24h

Atual

Mín

23

Máximo

24.15

Indicadores-chave

By Trading Economics

Rendimento

191K

-51M

Vendas

6.7M

106M

EPS

-0.46

Margem de lucro

-47.808

Funcionários

1,784

EBITDA

-2.1M

-46M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+67.3% upside

Dividendos

By Acuity

Próximos Ganhos

5 de nov. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

559M

2.6B

Abertura anterior

25.04

Fecho anterior

23

Zai Lab Ltd ADR Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

16 de out. de 2026, 23:52 UTC

News

Dell Technologies Inc shares are moving lower in after-market hours amid inflation concerns affecting tech valuations, despite being named a core AI partner for Honeywell.

16 de out. de 2026, 23:51 UTC

News

Baker Hughes Co. has a market capitalization of approximately $54.96 billion, experiencing a modest increase in after-market trading following Friday's close.

16 de out. de 2026, 23:46 UTC

News

Scholar Rock grants inducement equity awards for 61.02k shares to new employees as part of its strategy to attract talent for ISEMBLYD commercialization.

16 de out. de 2026, 23:46 UTC

News

Apollo Commercial Real Estate Finance Inc. plans to voluntarily delist from the NYSE, with the last trading day expected on November 6, 2026.

16 de out. de 2026, 23:41 UTC

News

General Electric Co shares are moving lower in after-market trading following a deal with CFM International for over 300 LEAP-1B engines for Turkish Airlines.

16 de out. de 2026, 23:41 UTC

News

Boeing Co. secures an $80 million contract from the U.S. Navy for the MQ-25A Stingray unmanned aircraft system, expected to be completed by October 2031.

16 de out. de 2026, 23:41 UTC

News

Tesla Inc shares are trading modestly lower in after-market hours, continuing a trend of decline and remaining significantly below their 20-day moving average.

16 de out. de 2026, 23:36 UTC

News

Hingham Institution for Savings reports third-quarter net income of $12.67 million, a decline from $17.30 million year-over-year, with overall performance metrics indicating a decrease.

16 de out. de 2026, 23:31 UTC

News

Celanese announces global price increases for LCP products, citing strong demand and rising costs, as shares decline in after-market trading.

16 de out. de 2026, 23:31 UTC

Correlated Moves
News

Coinbase Global Inc shares are trading modestly lower in after-market hours, influenced by a decline in Bitcoin prices and broader market trends.

16 de out. de 2026, 23:16 UTC

News

In after-market trading, Steel Dynamics Inc is rising, with analysts expecting earnings of approximately $5.40 per share on revenue of around $6.57 billion.

16 de out. de 2026, 23:12 UTC

Social Media
News

Morgan Stanley lowers Netflix's price target to $80 from $83, citing stagnant viewing hours and concerns over engagement trends ahead of earnings report.

16 de out. de 2026, 23:11 UTC

News

Lyft Inc shares declined in after-market trading following the announcement of its new premium chauffeur brand, Alcove, amid broader market weakness.

16 de out. de 2026, 23:11 UTC

News

RTX Corp's Raytheon business secured a $729 million contract for the Ku-band Radio Frequency Sensor and Coyote interceptor, boosting shares higher in after-market hours.

16 de out. de 2026, 23:06 UTC

News

Gartner Inc shares traded lower in after-market hours, following a decline from Friday's close amid concerns over rising U.S. import and export prices.

16 de out. de 2026, 23:06 UTC

Correlated Moves
News

Pomerantz LLP has initiated a class action lawsuit against FuelCell Energy Inc, alleging securities fraud and unlawful business practices involving the company and its officers.

16 de out. de 2026, 23:06 UTC

News

UPS is trading slightly lower in after-market hours, following a brief high earlier in the session, amid ongoing service enhancements and cost management efforts.

16 de out. de 2026, 23:02 UTC

News

Meta Platforms is set to report Q3 earnings on October 21, with analysts forecasting revenue of $63.31 billion and EPS of $5.60.

16 de out. de 2026, 23:02 UTC

Social Media
News

Bank of America Corp's Board has authorized cash dividends of $1.15K for Series F and G, and $0.27806 for Series E, payable in late 2026.

16 de out. de 2026, 23:02 UTC

News

Shah Capital has withdrawn its registration as an investment adviser and reduced its stake in Novavax to 6.39%, selling 2.87 million shares at $11.35 each.

16 de out. de 2026, 23:01 UTC

News

Citigroup maintains Neutral rating on Fiserv Inc and lowers its price target to $53 in a report published after market hours.

16 de out. de 2026, 23:01 UTC

News

Citigroup reaffirms Buy rating on Walt Disney Co and raises price target to $140, indicating confidence in the company's future performance.

16 de out. de 2026, 23:01 UTC

News

Viatris receives FDA approval for Ryzumvi to treat presbyopia in adults and seeks U.S. partners for commercialization under a licensing agreement with Opus Genetics.

16 de out. de 2026, 23:01 UTC

News

Goldman Sachs Group Inc shares are trading modestly lower in after-market hours, retracing to their lowest point of the day and below the 20-day moving average.

16 de out. de 2026, 23:01 UTC

News

Coca-Cola Co shares traded lower in after-market hours, despite KFC's upcoming switch to its beverages in U.S. restaurants starting January 2027.

16 de out. de 2026, 22:51 UTC

News

Navigator Holdings Ltd shares declined in after-market hours, continuing a downward trend for six consecutive sessions amid broader market declines.

16 de out. de 2026, 22:51 UTC

Correlated Moves
News

Power Integrations Inc granted 25.32k RSUs and 1.34k PSUs to 12 employees as a material inducement to employment, effective October 15, 2026.

16 de out. de 2026, 22:21 UTC

News

Moody's Corp shares are trading modestly lower in after-market hours, continuing a decline from Friday's close.

16 de out. de 2026, 20:31 UTC

News

Delek US Holdings, Inc. will hold a conference call on November 6, 2026, to discuss third-quarter results, with a press release before market open.

16 de out. de 2026, 20:21 UTC

News

Ames National Corp reported Q3 EPS of $0.80, surpassing the $0.68 estimate, with sales increasing to $20.42 million from $16.58 million year-over-year.

Comparação entre Pares

Variação de preço

Zai Lab Ltd ADR Previsão

Preço-alvo

By TipRanks

67.3% parte superior

Previsão para 12 meses

Média 39.333 USD  67.3%

Máximo 45 USD

Mínimo 36 USD

Com base em 3 analistas de Wall Street que oferecem metas de preço de 12 meses para Zai Lab Ltd ADR - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

3 ratings

3

Comprar

0

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Zai Lab Ltd ADR

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.
help-icon Live chat